Menu
Search
Home > Courses > Best of ACTHIV 2021: Principles of Antiretroviral Therapy for Treatment and Prevention

Best of ACTHIV 2021: Principles of Antiretroviral Therapy for Treatment and Prevention

Best of ACTHIV 2021: Principles of Antiretroviral Therapy for Treatment and Prevention
Play
Sorry, this learning module is not available for mobile devices.
ACTHIV
Original Release Date: 5/20/2021
Termination Date: 09/30/2022
Review Date: 9/30/2021
Presenter
  • Helen C. Koenig, MD, MPH
    Medical Director
    MacGregor Infectious Diseases Clinic; Associate Professor, University of Pennsylvania; Medical Director, PrEP Program, Philadelphia FIGHT
Learning Objectives / Desired Outcomes
At the completion of this educational activity, participants will:
  1. Select an HIV regimen for a patient newly diagnosed with HIV
  2. Identify the most common adverse effects and drug interactions associated with antiretroviral medications (ART)
  3. Discuss when and how to consider switching or simplifying an ART regimen
  4. Discuss patients for whom PEP or PrEP may be indicated, PrEP dosing regimens, and recommended monitoring on PrEP.
Presenter Bio
Helen Koenig, MD, MPH
Helen Koenig, MD, MPH is an Associate Professor of Clinical Medicine in the Infectious Diseases division at the Hospital of the University of Pennsylvania, where she serves as Medical Director of the MacGregor Infectious Diseases Practice and cares for primarily patients living with HIV. She also serves as the Medical Director of the PrEP program at Philadelphia FIGHT, an AIDS service organization in Philadelphia. She has received multiple grants looking at objective measures of adherence to PrEP as well as a SPNS grant to improved access to HIV prevention and treatment for young men of color who have sex with men using social media, and has been a co-investigator on more than 30 other clinical trials. She completed her undergraduate degree at Princeton University, her medical training at Cornell, residency and fellowship training at the University of Pennsylvania, and MPH and Preventive Medicine training at the Johns Hopkins Bloomberg School of Public Health.
Continuing Education Credit

This accredited continuing education activity is provided by American Academy of CME, Inc.

The 15th Annual American Conference for the Treatment of HIV (ACTHIV 2021) was held virtually May 20-22, 2021. The conference and this Best of ACTHIV web archive were supported by educational grants from Gilead Sciences; Janssen Therapeutics, Division of Janssen Products, LP; Merck & Co., Theratechnologies, and ViiV Healthcare.

FACULTY:

Helen C. Koenig, MD, MPH: Medical Director, MacGregor Infectious Diseases Clinic; Associate Professor, University of Pennsylvania; Medical Director, PrEP Program, Philadelphia FIGHT

Estimated time to complete: 45 minutes

TARGET AUDIENCE

This activity is intended for frontline providers of care to persons at risk for or who are living with HIV, including specialist and primary care Physicians, NPs, PAs, Nurses, and Pharmacists. Other HIV care team members are also encouraged to participate.

CREDIT

American Academy of CME is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians:

American Academy of CME, Inc. designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses Practitioners and Nurses: 

American Academy of CME, Inc. designates this educational activity for 0.75 contact hours (0.75 pharmacotherapeutic contact hours).

Physician Assistants:

American Academy of CME, Inc. has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid until September 30, 2022. PAs should only claim credit commensurate with the extent of their participation.

All other members of the HIV Care team will receive a certificate of participation.

HOW TO RECEIVE CREDIT 

There is no fee to participate in this activity. To obtain your certificate of credit/participation, you must read the CME/CE information, review the activity content, and complete the activity assessment and evaluation. Upon submission, your CE certificate will be emailed to you within 24 hours.

DISCLOSURES

According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relationships with any ineligible company(ies). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. Clinical content has been reviewed for fair balance and scientific objectivity, and all of the relevant financial relationships listed for these individuals have been mitigated.

The opinions expressed in this accredited continuing education activity are those of the faculty, and do not represent those of the Academy, or ACTHIV. This educational activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.

Off-Label Usage Disclosure

This activity will include discussion of growth hormone-releasing factor (GHRF) for weight loss.

Faculty Disclosure

Helen Koenig, MD, MPH : Advisory Board–Gilead Sciences, ViiV Healthcare; Consultant-Janssen, Theratechnologies; Shareholder–Gilead Sciences.

Planner Disclosures

The following individuals have no relevant financial relationships with ineligible companies to disclose: Beatrice Aladin, John Brooks, MD, Jose Castillo-Mancilla, MD, Sherrillyn Crooks, PA-C, Carlos del Rio, MD, Courtney V Fletcher, PharmD, Donna Futterman, MD, Rajesh Gandhi, MD, Mary Glenshaw, PhD, MPH, OTR/L, John JD Juchniewicz, MCIS, CHCP, FACEHP, H. Nina Kim, MD, MSc, Natalie Kirkwood, RN, BSN, JD, Harry Lampiris, MD, Sharon Lee, MD, Vincent Lo Re, MD, MSCE, Amber McCracken, Lorenzo McFarland, DHA, MPH, MSW, PMP, Paul Miniter, MS, Edward Moylan, RP, Asa Radix, MD, PhD, MPH, Dianne Rausch PhD, Renslow Sherer, MD, Cheryl Smith, MD, Susan Weiss, FNP-BC, MSN, AAHIVS

The following individuals have relevant financial relationships with commercial interests to disclose:

Jillian Baron, MD, MPH: Employee (Spouse/Partner) – IQVIA 

Roger Bedimo, MD, MS: Advisory Board - ViiV Healthcare, Merck, Theratechnologies

Michelle Cespedes, MD, MS: Advisory Board: Gilead Sciences, ViiV Healthcare; Grant/Research Support - Merck

Eric Daar, MD: Consultant, Gilead Sciences, Merck, Genentech; Grant/Research Support: Gilead Sciences, ViiV Healthcare, Merck  

Margaret Hoffman-Terry MD, FACP, AAHIVS: Advisory Board - ViiV Healthcare; Consultant - Gilead Sciences, ViiV Healthcare; Grant/Research Support - ViiV Healthcare; Consultant - Gilead Sciences, ViiV Healthcare

Igho Ofotokun, MD, MSc: Advisory Board – ViiV Healthcare, Accordant Health Services, Takeda 

Tonia Poteat PhD, MPH, PA-C: Grant Recipient/Research Support: Gilead Sciences, ViiV Healthcare

Jennifer Price, MD, PhD: Consultant - Theratechnologies; Shareholder (Spouse/partner) - AbbVie, Bristol Myers Squibb, Johnson & Johnson, Merck;.Grant Recipient/Research Support - Gilead Sciences, Merck

Jason Schafer, PharmD, MPH: Advisory Board - Merck, ViiV Healthcare, Grant Recipient/Research Support - Gilead Sciences, Merck

William Short, MD, MPH, FIDSA: Advisory Board - ViiV Healthcare, Consultant - ViiV Healthcare

Babaafemi Taiwo, MBBS: Advisory Board - Gilead Sciences, Merck, ViiV Healthcare; Consultant - Gilead Sciences, Merck, ViiV Healthcare

Pablo Tebas, MD: Consultant: Merck, ViiV Healthcare

Melanie Thompson, MD: Grant Recipient/Research Support - Cepheid Inc, Cytodyn Inc, Frontier Biotechnologies, Gilead Sciences, GlaxoSmithKline, Merck Sharp Dohme, ViiV Healthcare

Andrea Weddle, MSW: Advisory Board: Merck  

Privacy Policy

For more information about Academy’s privacy policy, please access: http://www.academycme.org/privacy.htm

For questions related to CME/CE credit, contact CEservices@academycme.org

Hardware/Software Requirements To access this activity hardware and software requirements are noted below.

Windows Requirements: • Operating system: Windows XP Service Pack 2 or later • Browser: Internet Explorer 7 or later, Mozilla Firefox 2.5 or later • Internet connection: DSL, cable modem, or other high-speed connection • Flash: Adobe Flash Player 9 or later 

Macintosh Requirements: • Operating system: Mac OS X v10.3 or later • Browser: Mozilla Firefox 2.5 or later • Internet connection: DSL, cable modem, or other high-speed connection • Flash: Adobe Flash Player 9 or later

Copyright 2021 American Academy of CME, Inc.

Resources: